Obtenez 3 mois à 0,99 $/mois + 20 $ de crédit Audible

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Beyond the Scan: How Pure Global Navigates the AI and Photon-Counting Revolution in CT Technology for Global Market Access

Beyond the Scan: How Pure Global Navigates the AI and Photon-Counting Revolution in CT Technology for Global Market Access

Beyond the Scan: How Pure Global Navigates the AI and Photon-Counting Revolution in CT Technology for Global Market Access

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 In this episode of MedTech Global Insights, we delve into the technological revolution transforming Computed Tomography (CT) scanners. We explore the two seismic shifts pushing the boundaries of medical imaging: the introduction of high-resolution photon-counting detectors and the integration of sophisticated Artificial Intelligence. We discuss how these advancements lead to clearer images, more accurate diagnoses, and enhanced patient safety by reducing radiation exposure. But beyond the technology, we uncover the immense and often underestimated challenge of bringing these life-saving innovations to a global market. The path is fraught with complex, fragmented, and ever-evolving regulatory hurdles that can stifle progress and delay patient access. Imagine this scenario: A European MedTech company develops a revolutionary AI-powered CT scanner that can detect early-stage cancers with 30% greater accuracy. After a lengthy and expensive process, they secure CE marking. However, their plan to enter the lucrative U.S. market hits a wall. The FDA classifies their unique AI algorithm as a novel technology, demanding a complex De Novo submission process with extensive clinical data and cybersecurity protocols not required in the EU. Meanwhile, their expansion plans for Asia are stalled by requirements for in-country testing in Japan and navigating China's stringent NMPA data privacy laws. This multi-front regulatory battle drains resources and delays their product from reaching patients worldwide. What You'll Learn: * What makes photon-counting CT technology a "game-changer" compared to traditional scanners? * How is Artificial Intelligence being used to make CT scans faster, safer, and more accurate? * Why is a medical device approved in Europe not automatically cleared for sale in the United States or Asia? * What are the biggest regulatory roadblocks when launching a new MedTech device with advanced software? * How can a unified regulatory strategy help access over 30 countries with a single process? * What are the critical differences in clinical data requirements between the FDA and EU MDR? * How does post-market surveillance for an AI-driven device differ from traditional hardware? * What role does a local representative play when registering a device in markets like Brazil or South Korea? To navigate these challenges and accelerate your global growth, contact us at info@pureglobal.com or visit https://pureglobal.com/
Pas encore de commentaire